Arrowhead Pharmaceuticals, Inc. (ARWR)
Company Info
| ISIN | US04280A1007 |
|---|---|
| CUSIP | 04280A100 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $3.54B |
|---|---|
| EPS | -$2.77 |
| PEG Ratio | -1.32 |
| Revenue (TTM) | $181.74M |
| Gross Profit (TTM) | $240.74M |
| EBITDA (TTM) | -$285.35M |
| Year Range | $20.67 - $42.48 |
| Target Price | $55.38 |
| Short % | 8.72% |
| Short Ratio | 5.10 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: ARWR vs. PODD, ARWR vs. QQQ, ARWR vs. XBI
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Arrowhead Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Arrowhead Pharmaceuticals, Inc. had a return of -26.37% year-to-date (YTD) and -25.89% in the last 12 months. Over the past 10 years, Arrowhead Pharmaceuticals, Inc. had an annualized return of 5.86%, while the S&P 500 had an annualized return of 10.43%, indicating that Arrowhead Pharmaceuticals, Inc. did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -26.37% | 5.29% |
| 1 month | -19.94% | -2.47% |
| 6 months | -13.31% | 16.40% |
| 1 year | -25.89% | 20.88% |
| 5 years (annualized) | 4.41% | 11.60% |
| 10 years (annualized) | 5.86% | 10.43% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 4.90% | -0.00% | -10.90% | |||||||||
| 2023 | -2.79% | -8.49% | -13.79% | 44.34% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Arrowhead Pharmaceuticals, Inc.(ARWR)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Arrowhead Pharmaceuticals, Inc. (ARWR) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Arrowhead Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Arrowhead Pharmaceuticals, Inc. was 99.96%, occurring on Dec 16, 2016. The portfolio has not yet recovered.
The current Arrowhead Pharmaceuticals, Inc. drawdown is 99.23%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.96% | Dec 17, 1993 | 3927 | Dec 16, 2016 | — | — | — |
Volatility
Volatility Chart
The current Arrowhead Pharmaceuticals, Inc. volatility is 12.08%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |